Preprint
Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic
bioRxiv
Cold Spring Harbor Laboratory
12/27/2025
DOI: 10.64898/2025.12.27.696684
PMCID: PMC12767509
PMID: 41497656
Abstract
HIV-1 resistance to therapeutics can emerge through diverse mutational routes, yet the determinants guiding pathway selection
remain unclear. Through comprehensive screening, we identified 18 mutations in the HIV-1 Env protein that enhance resistance to the FDA-approved small-molecule therapeutic temsavir. We then examined their occurrence in HIV-infected individuals who developed resistance on therapy. Only a subset of the resistance-enhancing mutations emerged
. On-treatment mutation frequencies correlated with their spontaneous emergence rates in temsavir-untreated individuals, and were governed by two parameters:
Probability of mutation appearance, determined by number and type of nucleotide changes required, and
Probability of mutation persistence, determined by Env functional and immune fitness. Notably, non-neutralizing antibodies commonly-elicited in HIV-infected individuals restricted emergence of multiple resistant forms, driving convergence to a narrow set of escape routes. These findings establish a quantitative framework for predicting therapeutic resistance and reveal how host-immunity constrains viral evolution during treatment.
Details
- Title: Subtitle
- Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic
- Creators
- Aaron N Gillman - University of IowaCassian M Birler - University of IowaRohith Rao Vujjini - University of IowaMohammad Fili - George Mason UniversitySamuel A McCarthy-Potter - University of IowaWilson Chen - ViiV HealthcareMadeline M Broghammer - University of IowaGuiping Hu - George Mason UniversityMargaret J Gartland - ViiV HealthcareManyu Prakash - ViiV HealthcareAnnika Helverson - University of IowaGrant Brown - University of IowaHillel Haim - University of Iowa
- Resource Type
- Preprint
- Publication Details
- bioRxiv
- DOI
- 10.64898/2025.12.27.696684
- PMID
- 41497656
- PMCID
- PMC12767509
- NLM abbreviation
- bioRxiv
- ISSN
- 2692-8205
- eISSN
- 2692-8205
- Publisher
- Cold Spring Harbor Laboratory; United States
- Language
- English
- Date posted
- 12/27/2025
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9985116170002771
Metrics
1 Record Views